New risks for pulmonary hypertension: Need for a large epidemiologic study

Chest

Volumn 130, Issue 6, 2006, Pages 1633-1635

  Willers, Elisabeth D ^a,b,c   Newman, John H ^a,b  

^a Vanderbilt University School of Medicine ^*

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOREX; AMPHETAMINE; COCAINE; DEXFENFLURAMINE; FENFLURAMINE; METHAMPHETAMINE; METHYLPHENIDATE;

APPETITE DISORDER; ATTENTION DEFICIT DISORDER; DISEASE CLASSIFICATION; DRUG TRAFFIC; EDITORIAL; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK ASSESSMENT; SEROTONIN RELEASE;

EID: 33845934896     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.6.1633     Document Type: Editorial

References (16)

1. Simonneau G, Galiè N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43(suppl), 5S-12S
2. McGee SM, McGee DN, McGee MB. Spontaneous intracerebral hemorrhage related to methamphetamine abuse: autopsy findings and clinical correlation. Am J Forensic Med Pathol 2004; 25:334-337
3. Shaw HE Jr, Lawson JG, Stutling RD. Amaurosis fugax and retinal vasculitis associated with methamphetamine inhalation. J Clin Neuroophthalmol 1985; 5:169-176
4. Department of Health and Human Services, Substance Abuse and Mental Health Sendees Administration, Office of Applied Studies. Substance abuse and mental health statistics. Available at: http://www.oas.samhsa.gov. Accessed August 28, 2006
5. Johnston LD, O'Malley PM, Bachman JG, et al. Monitoring the Future national survey results on drug use, 1975-2005: volume I. Secondary school students. Available at: http:// www.monitoringthefuture.org/pubs.html. Accessed August 28, 2006
6. Chin KM, Channick RN, Rubin, LJ. Is methamphetamine use associated with idiopathic pulmonary arterial hypertension. Chest 2006; 130:1657-1663
7. Schaiberger PH, Kennedy TC, Miller FC, et al. Pulmonary hypertension associated with long-term inhalation of "crank" methamphetamine. Chest 1993; 104:614-616
8. Herve P, Drouet L, Dosquet C, et al. Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. Am J Med 1990; 89:117-120
9. Herve P, Launay JM, Scrobohaci ML, et al. Increased plasma serotonin in primary pulmonary hypertension. Am J Med 1995; 99:249-254
10. Eddahibi S, Fabre V, Boni C, et al. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells: relationship with the mitogenic action of serotonin. Circ Res 1999; 84:329-336
11. Marcos E, Fadel E, Sanchez O, et al. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Circ Res 2004; 94:1263-1270
12. Rothman RB, Baumann, MH. Therapeutic and adverse actions of serotonin transporter substrates. Pharmacol Ther 2002; 95:73-88
13. Seiler KU, Wasserman O. MAO-inhibitory properties of anorectic drugs. J Pharm Pharmacol 1973; 25:576-578
14. Zolkowska D, Rothman RB, Baumann MH. Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease. J Pharmacol Exp Ther 2006; 318: 604-610
15. Reneman L, deWin MM, van den Brink W, et al. Neuroimaging findings with MDMA/ectasy: technical aspects, conceptual issues and future prospects. J Psychopharmacol 2006; 20:164-175
16. Spoont MR. Modulatory role of serotonin in neural information processing: implications for human psychopathology. Psychol Bull 1992; 112:330-350